Insider · CIK 0001239650

BURGESS DANIEL D

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001239650

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−875 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−450 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−150 sh	$221.50	−$33.2K	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.1K sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.5K sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,400 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−875 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2025-06-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,100
2024-12-17	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2024-07-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,125 sh	—	—	2,125
2024-05-23	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+67K sh	—	—	67,000
2023-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42.5K sh	—	—	42,500
2023-05-24	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2022-08-02	Nabriva Therapeutics plcS Sale	Director	SSale	−11.3K sh	$0.19	−$2,155.924	10,384
2022-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2022-05-25	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,000
2021-08-02	Nabriva Therapeutics plcS Sale	Director	SSale	−1,125 sh	$1.20	−$1,350	21,725
2021-07-28	Nabriva Therapeutics plcShare OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2021-07-28	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	22,850
2021-06-23	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-03	ABUSArbutus Biopharma Corp · Stock OptionsA Award	Director	AAward	+22K sh	—	—	22,000
2020-07-29	Nabriva Therapeutics plcStock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2020-07-29	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	53,500
2020-06-25	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-05-28	ABUSArbutus Biopharma Corp · Stock OptionsA Award	Director	AAward	+22K sh	—	—	22,000
2019-08-17	ABUSArbutus Biopharma Corp · Stock OptionsA Award	Director	AAward	+22K sh	—	—	22,000
2019-07-31	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+35K sh	—	—	35,000
2019-06-17	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-08-01	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2018-07-31	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+36K sh	$2.75	+$99K	36,000
2018-06-19	ABUSArbutus Biopharma Corp · Director Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2018-06-13	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-05-02	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+29K sh	—	—	29,000
2017-09-15	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+10.1K sh	—	—	10,100
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director	JOther	+20.2K sh	—	—	20,200
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director	JOther	+10.1K sh	—	—	10,100
2017-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-06-21	ABUSArbutus Biopharma Corp · Director Stock Option Grant (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2017-03-24	ABUSArbutus Biopharma Corp · Director Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2016-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-06-09	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-04-20	CDTXCidara Therapeutics, Inc.P Purchase	Director	PPurchase	+3,000 sh	$16.00	+$48K	3,000
2014-01-02	SANTARUS INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37K sh	$26.68	−$987K	0
2014-01-02	SANTARUS INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37K sh	$10.07	−$373K	0
2014-01-02	SANTARUS INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−37K sh	$25.27	−$935K	0

Recent filings

Accepted (ET)
Jan 74
BURGESS DANIEL D0001239650-26-000002
SEC(opens sec.gov)
Jun 184
BURGESS DANIEL D0001610618-25-000063
SEC(opens sec.gov)
Dec 194
BURGESS DANIEL D0001610618-24-000156
SEC(opens sec.gov)
Jul 194
BURGESS DANIEL D0001610618-24-000108
SEC(opens sec.gov)
May 244
BURGESS DANIEL D0001447028-24-000059
SEC(opens sec.gov)
Jun 234
BURGESS DANIEL D0001610618-23-000065
SEC(opens sec.gov)
May 264
BURGESS DANIEL D0001447028-23-000046
SEC(opens sec.gov)
Aug 44
BURGESS DANIEL D0001104659-22-086282
SEC(opens sec.gov)
Jun 244
BURGESS DANIEL D0001610618-22-000058
SEC(opens sec.gov)

Companies

Address

C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE SUITE 101

SAN DIEGO, CA, 92121